Electro-Acupuncture in Lung cancER : EALER Study

This multicentre, randomized controlled trial evaluates the effect and safety of acupuncture combing with PD-1 inhibitors plus chemotherapy in NSCLC. Participants will be randomly assigned to undergo either acupuncture or sham acupuncture concurrent with the initial four-six cycles of chemotherapy combined with PD-1 inhibitors.

NCT Number	NCT07337096
Lead Sponsor	Guangzhou University of Traditional Chinese Medicine Collaborators: The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, Jiangsu Province Hospital of Traditional Chinese Medicine
Conditions	Non Small Cell Lung Cancer, Accupuncture, PD-1 Inhibitors
Enrollment	424 participants
Start Date	2026-01-15
Primary Completion	2027-12 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-06-24